Clinical Trials for Coherus Oncology

PDT For Induction Therapy For Head And Neck Cancer

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Toripalimab With Chemotherapy for Sinus Cancer

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Study of CHS-114 in Participants With Advanced Solid Tumors

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors